Showing 641 - 660 results of 1,061 for search '"lymphoma"', query time: 0.08s Refine Results
  1. 641
  2. 642
  3. 643

    Is first-line treatment with polatuzumab vedotin–rituximab–cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) for previously untreated diffuse large B-cell lymphoma cost-effective in China? A cost-effectiveness analysis using a Markov model by Lin Yang, Ting Chen, Qiuling Zhao, Liangliang Dong, Wanfu Zhong, Wenbin Liu, Xiuliang Qiu, Ruyi Huang, Shengqiang Huang, Ruixiang Xie

    Published 2025-01-01
    “…Objective To evaluate the cost-effectiveness of polatuzumab vedotin–rituximab–cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) in CD20-positive patients with previously untreated diffuse large B-cell lymphoma (DLBCL) in China.Design A Markov model was constructed to analyse the cost-effectiveness of two strategies in CD20-positive patients with previously untreated DLBCL over a lifetime horizon: (1) pola-R-CHP and (2) rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP). …”
    Get full text
    Article
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650

    WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 1: EPIDEMIOLOGY, PATHOGENESIS, CLINICOPATHOLOGIC CHARACTERISTICS, DIFFERENTIAL DIAGNOSIS, RISK STRATIFICATION, AND C... by Michele Bibas, Shayna Sarosiek, Jorge J. Castillo

    Published 2024-06-01
    Subjects: “…Amyloidosis, Anemia, B cells, BCL2, Bruton tyrosine kinase, Bing-Neel syndrome, Bruton Tyrosine Kinase Inhibitors, Cryoglobulinemia, CXCR4, flow cytometry, hyperviscosity, lymphoplasmacytic lymphoma, MYD88, Waldenström Macroglobulinemia, Peripheral neuropathy.…”
    Get full text
    Article
  11. 651
  12. 652

    A Case of Chemotherapy-Refractory “THRLBCL like Transformation of NLPHL” Successfully Treated with Lenalidomide by Mamatha Siricilla, Lydia Irwin, Andres Ferber

    Published 2018-01-01
    “…Nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) is a subtype of nonclassical Hodgkin lymphoma (HL). …”
    Get full text
    Article
  13. 653

    Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL by Tingting Zhang, Zhenzhen Zhang, Xiubao Ren, Jin He, Zhengzi Qian, Bin Meng, Lei Jiao, Hengqi Liu, Lanfang Li, Lihua Qiu, Shiyong Zhou, Wenchen Gong, Huilai Zhang, Xianhuo Wang

    Published 2022-04-01
    “…The genetic characteristics of these immune checkpoints need to be further investigated in diffuse large B-cell lymphoma (DLBCL).Methods We performed whole-exome sequencing/targeted deep sequencing to investigate the genetic characteristics of PD-1/PD-L1/L2 and CD73/A2aR. …”
    Get full text
    Article
  14. 654
  15. 655

    Osteoblastic Metastases Mimickers on Contrast Enhanced CT by Fahad Al-Lhedan, Sam Samaan, Wanzhen Zeng

    Published 2017-01-01
    “…Secondary osseous involvement in lymphoma is more common compared to primary bone lymphoma. …”
    Get full text
    Article
  16. 656

    EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS by Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

    Published 2024-04-01
    “…T-cell LPDs have been linked to EBV in part of peripheral T-cell lymphomas, angioimmunoblastic T-cell lymphomas, extranodal nasal natural killer/T-cell lymphomas, and other uncommon histotypes. …”
    Get full text
    Article
  17. 657

    8 例 B细胞淋巴瘤的 T 细胞基因 CD4 V4 突变 及其相关蛋白的表达 by 苏祖兰, 金 亦, 赵美卿, 冯志英

    Published 2000-01-01
    “…其中小淋巴细胞性淋巴瘤( small lymphocyte lymphoma, SLL)和淋巴母细胞性淋巴瘤 ( lymphoblastic lymphoma, LBL)的 Fas,FasL 和 CD4 蛋白均为弱或无表达; 滤泡性淋巴瘤( follicular lymphoma, FL) 3 项均强表 达; 3 例弥漫性大 B 细胞淋巴瘤( diffuse large B cell lymphoma, DLBL)和 1例套细胞淋巴瘤(mantle cell lymphoma, MCL) Fas和 FasL 强表达,CD4无或弱表达。…”
    Get full text
    Article
  18. 658
  19. 659

    A Patient with a Right Atrium Mass and Congenital Heart Disease: A Challenging Diagnosis of a Stubborn Disease by Wenyan Wang, Huaicong Long, Zhiying Zhao

    Published 2016-01-01
    “…Cardiac lymphoma is extremely rare. An intracardiac mass has rarely been reported to be the cardiac involvement of extranodal lymphoma. …”
    Get full text
    Article
  20. 660

    In Vitro Studies of Anti-Hemolytic and Cytotoxic Activity of Procyanidin-Rich Extract from the Leaves of Actinidia arguta by Cyboran-Mikołajczyk Sylwia, Csonka Ákos, Molnar Joseph, Szabó Diana, Oszmiański Jan, Kleszczyńska Halina

    Published 2018-06-01
    “…The aim of this study was to determine the biological activity of the extract from leaves of kiwi in relation to cells of erythrocytes and lymphoma. This activity was determined by studying kiwi leaves extract anti-hemolytic, cytotoxic and antiproliferative activity, and its ability to change the physical properties of the cell membrane and inhibit multidrug resistance of mouse lymphoma cells. …”
    Get full text
    Article